The Efficiency of Sputum Cell Counts in Cystic Fibrosis

Overview

Journal Can Respir J

Publisher Wiley

Specialty Pulmonary Medicine

Date 2007 Mar 21

PMID 17372637

Citations 2

Authors

L Jayaram

N R Labiris

A Efthimiadis

H Valchos-Mayer

F E Hargreave

A P Freitag

Affiliations

Soon will be listed here.

Abstract

Background: Technical factors relating to processing viscid sputum in cystic fibrosis (CF) and their influence on the reproducibility and validity of cell counts need to be evaluated. In addition, the methods need to be standardized so that they can be applied clinically and in research.

Objective: To examine the efficiency, reliability and validity of processing small volumes of spontaneously expectorated sputum from subjects with CF.

Methods: Sputum was collected from adults with CF (n=35) and compared with sputum from adults with infective bronchitis or bronchiectasis (IB/B) (n=16), or with asthma or chronic obstructive pulmonary disease (AS/COPD) (n=25). Selected sputum (100 mg to 200 mg) was processed with dithiothreitol (0.1%) and filtered. Total cell count (TCC) and viability were obtained in a counting chamber and cytospins were prepared and stained with Wright's for a differential cell count. Sputum and filter remnant were processed for TCC, viability and differential cell count, and the efficiency was determined by comparing the mean loss in cell yield to the filter. Two different portions from the same sputum sample were processed for cell counts to determine reproducibility. Results were compared with those from IB/B and AS/COPD groups.

Results: Efficiency of cell dispersal was excellent and similar to that in AS/COPD and IB/B groups. Reproducibility of cell counts from two portions of a sputum sample was high (>or=0.80). CF sputum demonstrated a raised TCC and neutrophilia similar to IB/B but significantly higher than AS/COPD.

Conclusion: The selection method of evaluating cell counts in viscid CF sputum is efficient, reproducible and valid.

Citing Articles

Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.

Thaysen-Andersen M, Venkatakrishnan V, Loke I, Laurini C, Diestel S, Parker B J Biol Chem. 2015; 290(14):8789-802.

PMID: 25645918 PMC: 4423670. DOI: 10.1074/jbc.M114.631622.

Persistent sputum cellularity and neutrophils may predict bronchiectasis.

Drost N, Dsilva L, Rebello R, Efthimiadis A, Hargreave F, Nair P Can Respir J. 2011; 18(4):221-4.

PMID: 22059180 PMC: 3205103. DOI: 10.1155/2011/920465.

References

Nielsen H, Hvidt S, Sheils C, Janmey P . Elastic contributions dominate the viscoelastic properties of sputum from cystic fibrosis patients. Biophys Chem. 2004; 112(2-3):193-200. DOI: 10.1016/j.bpc.2004.07.019. View

Jayaram L, Parameswaran K, Sears M, Hargreave F . Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J. 2000; 16(1):150-8. DOI: 10.1034/j.1399-3003.2000.16a27.x. View

Bhowmik A, Seemungal T, Sapsford R, Devalia J, Wedzicha J . Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax. 1999; 53(11):953-6. PMC: 1745116. DOI: 10.1136/thx.53.11.953. View

Pizzichini E, Pizzichini M, Gibson P, Parameswaran K, Gleich G, Berman L . Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998; 158(5 Pt 1):1511-7. DOI: 10.1164/ajrccm.158.5.9804028. View

Cai Y, Carty K, Gibson P, Henry R . Comparison of sputum processing techniques in cystic fibrosis. Pediatr Pulmonol. 1996; 22(6):402-7. DOI: 10.1002/(SICI)1099-0496(199612)22:6<402::AID-PPUL9>3.0.CO;2-K. View

Pizzichini M, Popov T, Efthimiadis A, Hussack P, Evans S, Pizzichini E . Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996; 154(4 Pt 1):866-9. DOI: 10.1164/ajrccm.154.4.8887576. View

. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152(3):1107-36. DOI: 10.1164/ajrccm.152.3.7663792. View

Popov T, Gottschalk R, Kolendowicz R, Dolovich J, Powers P, Hargreave F . The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 1994; 24(8):778-83. DOI: 10.1111/j.1365-2222.1994.tb00990.x. View

Ramsey B, Boat T . Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr. 1994; 124(2):177-92. DOI: 10.1016/s0022-3476(94)70301-9. View

10.

Crapo R, Morris A, Gardner R . Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981; 123(6):659-64. DOI: 10.1164/arrd.1981.123.6.659. View

11.

Picot R, Das I, Reid L . Pus, deoxyribonucleic acid, and sputum viscosity. Thorax. 1978; 33(2):235-42. PMC: 470876. DOI: 10.1136/thx.33.2.235. View

12.

Reinhardt N, Chen C, Loppow D, Schink T, Kleinau I, Jorres R . Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL. Eur Respir J. 2003; 22(3):497-502. DOI: 10.1183/09031936.03.00043603. View

13.

Aitken M, Greene K, Tonelli M, Burns J, Emerson J, Goss C . Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis. Chest. 2003; 123(3):792-9. DOI: 10.1378/chest.123.3.792. View

14.

Green R, Brightling C, McKenna S, Hargadon B, Parker D, Bradding P . Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002; 360(9347):1715-21. DOI: 10.1016/S0140-6736(02)11679-5. View

15.

Efthimiadis A, Spanevello A, Hamid Q, Kelly M, Linden M, Louis R . Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl. 2002; 37:19s-23s. DOI: 10.1183/09031936.02.00001902. View

16.

Sagel S, Kapsner R, Osberg I, Sontag M, Accurso F . Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med. 2001; 164(8 Pt 1):1425-31. DOI: 10.1164/ajrccm.164.8.2104075. View

17.

Pavord I, Brightling C, Woltmann G, Wardlaw A . Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999; 353(9171):2213-4. DOI: 10.1016/S0140-6736(99)01813-9. View

18.

Leigh R, Pizzichini M, Morris M, Maltais F, Hargreave F, Pizzichini E . Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J. 2006; 27(5):964-71. DOI: 10.1183/09031936.06.00072105. View

19.

Henig N, Tonelli M, Pier M, Burns J, Aitken M . Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax. 2001; 56(4):306-11. PMC: 1746031. DOI: 10.1136/thorax.56.4.306. View

20.

Brightling C, Monteiro W, WARD R, Parker D, Morgan M, Wardlaw A . Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000; 356(9240):1480-5. DOI: 10.1016/S0140-6736(00)02872-5. View